+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Diagnostic Enzyme Market Report 2025 - Product Thumbnail Image

Diagnostic Enzyme Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
X-linked Retinitis Pigmentosa - Pipeline Insight, 2025 - Product Thumbnail Image

X-linked Retinitis Pigmentosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
From
From
Global Auto Injector Market Outlook 2030 - Product Thumbnail Image

Global Auto Injector Market Outlook 2030

  • Report
  • October 2021
  • 199 Pages
  • Global
From
From
Oligonucleotide Therapy Market Report 2025 - Product Thumbnail Image

Oligonucleotide Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Loading Indicator